Infectious Diseases
News
FDA approves new single-tablet HIV treatment
The U.S. Food and Drug Administration has approved the fixed-dose combination tablet Genvoya as a complete regimen for the treatment of HIV-1...
News
Zika virus adds to dengue and chikungunya threat in Brazil
Clusters of acute exanthematous illness since 2014 in Brazil have been linked to the Zika virus, but research also suggests the concurrent...
News
Louse-borne relapsing fever appears again in Europe
The reemergence of an early-20th-century fever is an example of how increased migration from war-torn and resource-poor countries has created new...
News
Number of TB-caused deaths fall, but disease still kills 1 million-plus
Tuberculosis (TB) mortality has fallen 47% since 1990 and the reporting on incidences of the disease has improved. Still, TB remains one of the...
Conference Coverage
New antifungals effective with shorter treatment course for tinea pedis
Conference Coverage
SDEF: Improved responses with newer topical onychomycosis treatments
News
Early diagnosis of primary amebic meningoencephalitis key to treatment
A 2014 Florida case of primary amebic meningoencephalitis – a rare, typically fatal infection of the brain – is a reminder to physicians of the...
Conference Coverage
AAP: Most parents develop vaccine preferences before pregnancy
Most parents know whether they want to vaccinate their child before the child is even conceived, a study showed.
News
Quadrivalent HPV vaccine treats recalcitrant warts in preadolescent children
A quadrivalent human papillomavirus vaccine was effective at removing therapy-resistant warts from children aged 9-11 years.
News
Genomic sequencing technology reveals weakness in malaria vaccine
Genetic variability in the surface protein targeted by an experimental malaria vaccine explains why the vaccine provided only moderate protection...
Conference Coverage
Norovirus sends 1.6 million to doctors every year
Norovirus infections send about 1.6 million people to the doctor every year in the United States, according to the first active surveillance study...